Nonsteroidal antiinflammatory drugs and colorectal cancer

Epidemiologic Reviews

Volumn 18, Issue 2, 1996, Pages 205-217

  Berkel, Hans J ^a   Holcombe, Randall F ^a   Middlebrooks, Mark ^a   Kannan, Krishnaswamy ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONIC ACID; CARPROFEN; IBUPROFEN; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; SULINDAC;

APOPTOSIS; BREAST CANCER; CANCER RISK; CLINICAL TRIAL; COLON POLYP; COLORECTAL CANCER; HUMAN; NONHUMAN; PRIORITY JOURNAL; RECTUM ADENOMA; RECTUM POLYP; REVIEW;

EID: 0030515264     PISSN: 0193936X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.epirev.a017926     Document Type: Review

References (16)

1. Parker SL, Tong T, Bolden S, et al. Cancer statistics, 1996. CA Cancer J Clin 1996;46:5-27.
2. Howe HL, Bernstein L, Chen V. et al. Cancer incidence in North America, 1988-1991. San Francisco, CA: North American Association for Colon Cancer Registries, 1995.
3. Canadian cancer statistics, 1995. Toronto, Ontario. Canada: National Cancer Institute of Canada, 1995.
4. Potter JD, Slattery ML, Bostick RM, et al. Colon cancer: a review of the epidemiology. Epidemiol Rev 1993:15: 499-545.
5. Steinmetz K A, Potter JD. Vegetables, fruit, and cancer. II. Mechanisms. Cancer Causes Control 1991;2:427-42.
6. Heilbrun LK, Nomura A, Hankin JH, et al. Diet and colorectal cancer with special reference to fiber intake. Int J Cancer 1989;44:1-6.
7. McEvoy GK, ed. American Hospital Formulary Service 95 drug information. Bethesda, MD: American Society of Health-System Pharmacists, 1995.
8. Katzung BG, ed. Basic and clinical pharmacology. 6th ed. Norwalk, CT: Appleton and Lange, 1995.
9. Gelman CR, Rumack BH, Hess AJ, eds. DRUGDEX(R) system. Englewood, CO: Micromedex Inc, 1996.
10. Evans WE, Schentag JJ, Jusko WJ, eds. Applied pharmacokinetics: principles of therapeutic drug monitoring. 3rd ed. Vancouver, WA: Applied Therapeutics Inc, 1992.
11. Waddell WR, Loughry RW. Sulindac for polyposis of the colon. J Surg Oncol 1983;24:83-7.
12. Gonzaga RA, Lima FR, Carneiro S, et al. Sulindac treatment for familial polyposis coli. (Letter). Lancet 1985;1:751.
13. Waddell WR. Ganser GF, Cerise EJ, et al. Sulindac for polyposis of the colon. Am J Surg 1989;157:175-9.
14. Friend WG. Sulindac suppression of colorectal polyps in Gardner's syndrome. Am Fam Physician 1990;41:891-4.
15. Labayle D, Fischer D, Vielh P, et al. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology 1991;101:653-9.
16. Rigau J, Pique JM, Rubio E, et al. Effects of long-term sulindac therapy on colonie polyposis. Ann Intern Med 1991;115:952-4.